MTOR and lung cancer: These data suggest that Ad-VT plays a role in chemotherapy resistance at the molecular level by affecting the protein expression of constituents of the PI3K/Akt/mTOR signaling pathway, which can be exploited to improve the sensitivity of drug-resistant lung cancer cell lines to chemotherapy.